review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1013546030 |
P356 | DOI | 10.1007/S40265-014-0200-1 |
P698 | PubMed publication ID | 24610704 |
P50 | author | Sohita Dhillon | Q102146188 |
P2093 | author name string | Madeleine Clarke | |
P2860 | cites work | Therapeutics for Circadian Rhythm Sleep Disorders | Q24600160 |
Melatonin and its analogs in insomnia and depression | Q28249175 | ||
Light, melatonin and the sleep-wake cycle | Q33921442 | ||
Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonist | Q34186458 | ||
Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system | Q34277688 | ||
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. | Q34894399 | ||
Melatonin and its agonists: an update | Q46338504 | ||
Relationship between Napping and Melatonin in the Blind | Q61055166 | ||
P433 | issue | 4 | |
P921 | main subject | tasimelteon | Q7687250 |
P304 | page(s) | 505-511 | |
P577 | publication date | 2014-03-01 | |
P1433 | published in | Drugs | Q3040094 |
P1476 | title | Tasimelteon: first global approval | |
P478 | volume | 74 |
Q57446284 | Can we Fix a Broken Clock? |
Q39040818 | Chronomedicine and type 2 diabetes: shining some light on melatonin |
Q38271292 | Current Phase II investigational therapies for insomnia |
Q39147457 | Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind. |
Q34440574 | Melatonergic drugs in development |
Q41181255 | New MT₂ Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists |
Q47557441 | New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation |
Q28387407 | Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial |
Q91784560 | Sleep-Wake Disturbance Related to Ocular Disease: A Systematic Review of Phase-Shifting Pharmaceutical Therapies |
Q38247486 | Tasimelteon: a melatonin receptor agonist for non-24-hour sleep-wake disorder |
Q34358480 | Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders |
Search more.